A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.


Phase 1 Results N/A

Summary of Purpose

A study to investigate the concentrations of a new drug DPOC-4088 in blood, and to study the effect of this drug on blood clotting parameters. Furthermore the relation between the blood concentrations and the blood clotting effect will be investigated. Safety will be investigated as well. The objective of these... Trial Stopped: Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 February 2015.

1 Feb 2012 19 Jul 2012 1 Sep 2012 1 Sep 2012 1 Jul 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Pharmacokinetics/Dynamics Study